Literature DB >> 16322275

Insulin pump therapy and health-related quality of life in children and adolescents with type 1 diabetes.

Jessica M Valenzuela1, Anna Maria Patino, Judith McCullough, Christine Ring, Janine Sanchez, Margaret Eidson, Robin Nemery, Alan M Delamater.   

Abstract

OBJECTIVES: To compare the health-related quality of life (HRQOL) of youths on injection regimens to those prescribed insulin pump therapy and examine factors related to HRQOL in youths with type 1 diabetes.
METHODS: An ethnically diverse group of youths (n = 160, ages 5-17 years) with type 1 diabetes and their caretakers completed family, parent, and child adjustment measures, as well as measures of generic- and disease-specific HRQOL. Metabolic control and regimen information were assessed through medical records.
RESULTS: HRQOL was unrelated to regimen prescription. Child, family, and parent adjustment variables were significantly related to HRQOL, whereas other demographic and clinical variables were relatively less important.
CONCLUSIONS: Present findings indicate that insulin pump therapy does not have negative implications for HRQOL. They also suggest that interventions aiming to improve HRQOL in this population should target child, parent, and family adjustment and not focus solely on disease-related outcomes.

Entities:  

Mesh:

Year:  2005        PMID: 16322275     DOI: 10.1093/jpepsy/jsj088

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  21 in total

1.  Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study.

Authors:  Naglaa Ibrahim Mesbah; Nehad Abd-El-Raheem Taha; Zahra Nema Rahme; Faten Fawzi Sukkar; Dina Mohamed Omar
Journal:  Med Princ Pract       Date:  2019-09-27       Impact factor: 1.927

Review 2.  Use of technology when assessing adherence to diabetes self-management behaviors.

Authors:  Kimberly A Driscoll; Deborah Young-Hyman
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

3.  General and diabetes-specific stress in adolescents with type 1 diabetes.

Authors:  Kaitlyn Rechenberg; Robin Whittemore; Margaret Holland; Margaret Grey
Journal:  Diabetes Res Clin Pract       Date:  2017-05-16       Impact factor: 5.602

4.  Parent and family stress factors predict health-related quality in pediatric patients with new-onset epilepsy.

Authors:  Yelena P Wu; Katherine Follansbee-Junger; Joseph Rausch; Avani Modi
Journal:  Epilepsia       Date:  2014-03-27       Impact factor: 5.864

5.  The effect of parental mental health on proxy reports of health-related quality of life in children with sickle cell disease.

Authors:  Julie A Panepinto; Raymond G Hoffmann; Nicholas M Pajewski
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

Review 6.  Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress.

Authors:  Diana Naranjo; Molly L Tanenbaum; Esti Iturralde; Korey K Hood
Journal:  J Diabetes Sci Technol       Date:  2016-06-28

7.  Quality of life in children with Type 1 diabetes: a comparison of general and diabetes-specific measures and support for a unitary diabetes quality-of-life construct.

Authors:  T R Nansel; J Weisberg-Benchell; T Wysocki; L Laffel; B Anderson
Journal:  Diabet Med       Date:  2008-11       Impact factor: 4.359

8.  Generic and diabetes-specific parent-child behaviors and quality of life among youth with type 1 diabetes.

Authors:  Jill Weissberg-Benchell; Tonja Nansel; Grayson Holmbeck; Rusan Chen; Barbara Anderson; Tim Wysocki; Lori Laffel
Journal:  J Pediatr Psychol       Date:  2009-03-06

9.  Predictors of diabetes-related quality of life after transitioning to the insulin pump.

Authors:  Marisa E Hilliard; Marcie Goeke-Morey; Fran R Cogen; Celia Henderson; Randi Streisand
Journal:  J Pediatr Psychol       Date:  2008-06-24

10.  Impact of family income and sickle cell disease on the health-related quality of life of children.

Authors:  Julie A Panepinto; Nicholas M Pajewski; Lisa M Foerster; Svapna Sabnis; Raymond G Hoffmann
Journal:  Qual Life Res       Date:  2008-11-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.